Document is current
Any future updates will be listed below
-
Authors
Jeyanathan, Mangalakumari
Afkhami, Sam
D’Agostino, Michael R.
Satia, Imran
Fritz, Dominik K.
Miyasaki, Kate
Ang, Jann C.
Zganiacz, Anna
Howie, Karen J.
Swinton, Marilyn
Aguirre, Emilio
Zheng, Michael B.
Kazhdan, Natallia
Dvorkin-Gheva, Anna
Mbuagbaw, Lawrence
Medina, Maria Fe C.
Diab, Nermin
Brister, Danica L.
Gauvreau, Gail M.
Lichty, Brian D. https://orcid.org/0000-0003-4514-1037
Miller, Matthew S. https://orcid.org/0000-0003-3426-5069
Smaill, Fiona https://orcid.org/0000-0002-1305-6260
Xing, Zhou https://orcid.org/0000-0001-7856-0663
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research
- License Information
-
More Information
Article History
Received: 28 September 2024
Accepted: 30 May 2025
First Online: 2 July 2025
Competing interests
: B.D.L., Z.X., and F.S. are listed as co-inventors on the patent “Novel COVID vaccine and method for delivery” (PCT/CA2022/051107, Pub date: Jan 19, 2023 which is currently in the national phase with ID# WO2023283745). M.S.M., B.D.L., Z.X., and F.S. are co-founders of AeroImmune Inc. The other authors declare no competing interests.
